Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a leading developer of spider silk-based ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Start-ups focused in artificial intelligence, software development, and cybersecurity are gathering in cities including Ann Arbor and Grand ... medical innovation are biotechnology and healthcare.

Coe, an assistant professor of clinical pharmacy at the University of Michigan in Ann Arbor, answered questions about how to prevent errors for "The Experts Say," the American Heart Association ...

JENA, Germany, Jan. 23, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced ...

Arbor Realty Trust (ABR) closed the most recent trading day at $13.60, moving -1.45% from the previous trading session. This move lagged the S&P 500's daily gain of 0.88%. Meanwhile, the Dow ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...

The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023. Moderna plans to move mRNA-1018 to a Phase 3 trial. Shares of Moderna (MRNA) took off Tuesday ...